Form 8-K - Current report:
SEC Accession No. 0000950170-25-090384
Filing Date
2025-06-26
Accepted
2025-06-26 16:06:16
Documents
10
Period of Report
2025-06-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rani-20250620.htm   iXBRL 8-K 46721
  Complete submission text file 0000950170-25-090384.txt   156906

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rani-20250620.xsd EX-101.SCH 26034
12 EXTRACTED XBRL INSTANCE DOCUMENT rani-20250620_htm.xml XML 4939
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 251080405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)